| Dr Abram John Elsenraat, MD | |
|
1600 E Broadway, Columbia, MO 65201-5844 | |
| (573) 815-6262 | |
| Not Available |
| Full Name | Dr Abram John Elsenraat |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 22 Years |
| Location | 1600 E Broadway, Columbia, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043357452 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083A0100X | Preventive Medicine - Aerospace Medicine | 2003022490 (Missouri) | Secondary |
| 207L00000X | Anesthesiology | 2003022490 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Boone Hospital Center | Columbia, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mid-america Anesthesia Consultants, Pc | 6305837626 | 42 |
News Archive
Johns Hopkins University researchers have received an estimated $7.5 million National Institutes of Health grant to clinically test what would be the first treatment to prevent or delay the onset of Alzheimer's dementia.
The U.S. Food and Drug Administration has approved Tysabri (natalizumab) for the treatment of moderate-to-severe Crohn's disease in patients with evidence of inflammation who have had an inadequate response to, or are unable to tolerate, conventional Crohn's disease therapies.
Mylan Inc. today announced that it has launched Risedronate Sodium Tablets USP, 150 mg, the generic version of Warner Chilcott's Actonel Tablets. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for the treatment and prevention of osteoporosis in postmenopausal women.
Previously hidden obesity-related genes have been uncovered from old experiments by researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital.
› Verified 2 days ago
| Entity Name | Mid-america Anesthesia Consultants, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083728463 PECOS PAC ID: 6305837626 Enrollment ID: O20040524000952 |
News Archive
Johns Hopkins University researchers have received an estimated $7.5 million National Institutes of Health grant to clinically test what would be the first treatment to prevent or delay the onset of Alzheimer's dementia.
The U.S. Food and Drug Administration has approved Tysabri (natalizumab) for the treatment of moderate-to-severe Crohn's disease in patients with evidence of inflammation who have had an inadequate response to, or are unable to tolerate, conventional Crohn's disease therapies.
Mylan Inc. today announced that it has launched Risedronate Sodium Tablets USP, 150 mg, the generic version of Warner Chilcott's Actonel Tablets. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for the treatment and prevention of osteoporosis in postmenopausal women.
Previously hidden obesity-related genes have been uncovered from old experiments by researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Abram John Elsenraat, MD 1316 Old Highway 63 S, Suite 102, Columbia, MO 65201-6092 Ph: (573) 875-8838 | Dr Abram John Elsenraat, MD 1600 E Broadway, Columbia, MO 65201-5844 Ph: (573) 815-6262 |
News Archive
Johns Hopkins University researchers have received an estimated $7.5 million National Institutes of Health grant to clinically test what would be the first treatment to prevent or delay the onset of Alzheimer's dementia.
The U.S. Food and Drug Administration has approved Tysabri (natalizumab) for the treatment of moderate-to-severe Crohn's disease in patients with evidence of inflammation who have had an inadequate response to, or are unable to tolerate, conventional Crohn's disease therapies.
Mylan Inc. today announced that it has launched Risedronate Sodium Tablets USP, 150 mg, the generic version of Warner Chilcott's Actonel Tablets. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for the treatment and prevention of osteoporosis in postmenopausal women.
Previously hidden obesity-related genes have been uncovered from old experiments by researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital.
› Verified 2 days ago
Sarah Marie Von Thaer, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: One Hospital Dr, Columbia, MO 65212 Phone: 573-882-2568 Fax: 855-903-0985 | |
Ryan Daniel Montgomery, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Dr, Columbia, MO 65212 Phone: 573-882-2568 Fax: 855-903-0985 | |
Thomas Wesley Meyer, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1600 E Broadway, Columbia, MO 65201 Phone: 573-815-6262 Fax: 573-815-2308 | |
Dr. Oleksiy Mykhaylovych Zyernov, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Dr, Dc056.20, Columbia, MO 65212 Phone: 573-882-2568 Fax: 885-903-0985 | |
Frederick T O'donnell, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Dr, Columbia, MO 65201 Phone: 573-882-2568 Fax: 573-882-2226 | |
Stephanie Elizabeth Cain, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 1 Hospital Dr, Columbia, MO 65212 Phone: 573-884-3466 | |
Eric Kenneth Jagim, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Dr, Columbia, MO 65212 Phone: 573-882-2568 Fax: 573-882-2226 |